2015
Outcomes in Mild Acute Ischemic Stroke Treated With Intravenous Thrombolysis: A Retrospective Analysis of the Get With the Guidelines–Stroke Registry
Romano J, Smith E, Liang L, Gardener H, Camp S, Shuey L, Cook A, Campo-Bustillo I, Khatri P, Bhatt D, Fonarow G, Sacco R, Schwamm L. Outcomes in Mild Acute Ischemic Stroke Treated With Intravenous Thrombolysis: A Retrospective Analysis of the Get With the Guidelines–Stroke Registry. JAMA Neurology 2015, 72: 423-431. PMID: 25642650, DOI: 10.1001/jamaneurol.2014.4354.Peer-Reviewed Original ResearchConceptsRecombinant tissue plasminogen activatorHealth Stroke Scale scoreStroke Scale scoreSymptomatic intracranial hemorrhageShort-term outcomesIntravenous recombinant tissue plasminogen activatorGuidelines-Stroke registrySerious systemic hemorrhageAcute ischemic strokeLength of stayMild strokeTreatment complicationsIschemic strokeIntracranial hemorrhageScale scoreSymptom onsetSerious complicationsRetrospective analysisSystemic hemorrhageMild acute ischemic strokeNational InstituteWorse short-term outcomesBaseline National InstitutesHigher National InstitutesQuality improvement registry
2012
Venous Thromboembolism in the Get With The Guidelines-Stroke Acute Ischemic Stroke Population: Incidence and Patterns of Prophylaxis
Douds G, Hellkamp A, Olson D, Fonarow G, Smith E, Schwamm L, Cockroft K. Venous Thromboembolism in the Get With The Guidelines-Stroke Acute Ischemic Stroke Population: Incidence and Patterns of Prophylaxis. Journal Of Stroke And Cerebrovascular Diseases 2012, 23: 123-129. PMID: 23253528, DOI: 10.1016/j.jstrokecerebrovasdis.2012.10.018.Peer-Reviewed Original ResearchConceptsVTE prophylaxisIschemic stroke patientsDeep vein thrombosisVenous thromboembolismProphylaxis ratesPulmonary emboliStroke patientsIntra-arterial tissue plasminogen activatorAcute ischemic stroke populationHospitalized ischemic stroke patientsIncidence of VTEAcute ischemic stroke patientsAtrial fibrillation/flutterIschemic stroke populationPatterns of prophylaxisAcute ischemic strokePeripheral vascular diseaseOverall rateTissue plasminogen activatorMedical comorbiditiesAnalysis cohortIschemic strokeVein thrombosisSerious complicationsStroke population